Thiopurine methyltransferase phenotypes and genotypes in Brazilians

被引:32
|
作者
Reis, M [1 ]
Santoro, A [1 ]
Suarez-Kurtz, G [1 ]
机构
[1] Inst Nacl Canc, Coordenacao Pesquisa, Div Farmacol, BR-20231050 Rio De Janeiro, RJ, Brazil
来源
PHARMACOGENETICS | 2003年 / 13卷 / 06期
关键词
TPMT; genetic polymorphism; Brazilians; thiopurines;
D O I
10.1097/00008571-200306000-00009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The polymorphism of thiopurine methyltransferase (TPMT) was studied in 306 healthy Brazilians who were classed, on the basis of self-declared colour and ancestry, as Euro-derived (n = 81), Afro-derived (n = 18) or having interethnic admixture (n = 204). TPMT activity (range 0.17-25.93 U) displayed a trimodal distribution of high (> 11.3 U; 9% of individuals), intermediate (5-11.3 U; 9.8%) and low (0.17 U; 0.3%) phenotypes. The occurrence of the TPMT mutations 238G>C, 460G>A and 719A>G was investigated in all individuals with low or intermediate phenotype, and in 43 with high-activity phenotype. None and two mutant alleles were associated with high- or low-activity phenotypes, respectively, whereas one mutant allele was detected in 26 of the 30 intermediate phenotype individuals. The allele frequencies of TPMT*2, TPMT*3A and TPMT*3C did not differ between individuals classed as Euro-derived (0.76%, 2.03% and 2.54%, respectively) or having interethnic admixture (0.60%, 1.81% and 1.81%, respectively). Furthermore, within each of these groups, the frequencies of TPMT*3A and TPMT*3C were not significantly different. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:371 / 373
页数:3
相关论文
共 50 条
  • [31] Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis
    Hindorf, Ulf
    Jahed, Khatoon
    Bergquist, Annika
    Verbaan, Hans
    Prytz, Hanne
    Wallerstedt, Sven
    Werner, Marten
    Olsson, Rolf
    Bjoernsson, Einar
    Peterson, Curt
    Almer, Sven H. C.
    JOURNAL OF HEPATOLOGY, 2010, 52 (01) : 106 - 111
  • [32] No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease
    Lindqvist, M.
    Hindorf, U.
    Almer, S.
    Soderkvist, P.
    Strom, M.
    Hjortswang, H.
    Peterson, C.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1033 - 1037
  • [33] Nomenclature for alleles of the thiopurine methyltransferase gene
    Appell, Malin L.
    Berg, Jonathan
    Duley, John
    Evans, William E.
    Kennedy, Martin A.
    Lennard, Lynne
    Marinaki, Tony
    McLeod, Howard L.
    Relling, Mary V.
    Schaeffeler, Elke
    Schwab, Matthias
    Weinshilboum, Richard
    Yeoh, Allen E. J.
    McDonagh, Ellen M.
    Hebert, Joan M.
    Klein, Teri E.
    Coulthard, Sally A.
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (04): : 242 - 248
  • [34] Thiopurine methyltransferase in acute lymphoblastic leukemia
    Relling, MV
    Pui, CH
    Cheng, C
    Evans, WE
    BLOOD, 2006, 107 (02) : 843 - 844
  • [35] Recent advances in the pharmacogenomics of thiopurine methyltransferase
    Coulthard S.A.
    Hall A.G.
    The Pharmacogenomics Journal, 2001, 1 (4) : 254 - 261
  • [36] A global view of thiopurine methyltransferase pharmacogenetics
    Patel, MK
    Van Booven, DJ
    McLeod, HL
    PHARMACOTHERAPY, 2004, 24 (10): : 1458 - 1459
  • [37] Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson, J
    Ansari, A
    Marinaki, T
    Duley, J
    ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 : 294 - 302
  • [38] Role of Thiopurine Metabolite Testing and Thiopurine Methyltransferase Determination in Pediatric IBD
    Benkov, Keith
    Lu, Ying
    Patel, Ashish
    Rahhal, Riad
    Russell, Gary
    Teitelbaum, Jonathan
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 56 (03): : 333 - 340
  • [39] Clinically Actionable Genotypes Among Brazilians
    Suarez-Kurtz, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (01) : 25 - 26
  • [40] Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs
    Sheffield, Leslie J.
    Irving, Peter
    Gupta, Arun
    Byron, Keith
    Macrae, Finlay A.
    Phillimore, Hazel
    Dronavalli, Mithilesh
    Rose, Rosemary
    George, Peter
    Walmsley, Trevor
    Dixon, Barbara
    Poole, Susan
    Dooley, Michael
    Sparrow, Miles
    PHARMACOGENOMICS, 2009, 10 (07) : 1091 - 1099